Neuro-Oncology Clinical Trials


Protocol ID

Official Title

Principal Investigator

Lead CRC

Disease Site

Phase

PRT811-01

ClinicalTrials.gov #

NCT04089449

A Phase 1, Open-Label, Multicenter, Dose Escalation and Expansion Study of PRT811 in Subjects with Advanced Solid Tumors, CNS Lymphoma, and Recurrent High-Grade Gliomas Dr. Allan Krutchik Joanne Huff Gliomas I